On 18th November, the new product launch of Hengan Fulin Lidian® Collagen Patch Dressing was successfully closed at the headquarters of Jingdong Health in Beijing.Leaders and experts from various parties witnessed this launch. This project is the first Class III medical device incubated by Healtech CDMO Center based on the whole process of ‘Marketing Authorization solution’ and formally entered into the commercialisation stage, which has an important milestone significance.It is the world's first new product that applies new medical material Extracellular Matrix (ECM) to the field of medical aesthetics in a large-scale and industrialised manner, and it sets off the clinical application of extracellular matrix .

Dikang Pharma's decellularized extracellular matrix (d-ECM) had obtained invention patent authorization from the China National Intellectual Property Administration and master file registration from the National Medical Products Administration.

Healtech Beijing CDMO Center has been recognized as the Beijing “Specialized and Sophisticated” Small and Medium-sized Enterprise - It is another important qualification after National High-tech Enterprise, Zhongguancun High-tech Enterprise and Beijing Innovative Small and Medium-sized Enterprise.